Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome

Browse by...

Deposit

Highlights

More informations

Title		Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome
Authors		Zilli, Thomas Jorcano, S Escudé, L Linero, D Rouzaud, M Dubouloz, A Miralbell, Raymond
Published in		Clinical Oncology. 2014, vol. 26, no. 6, p. 316-22
Abstract		To evaluate the tolerance and preliminary outcome of prostate cancer patients at high risk of lymph node involvement treated with normofractionated whole pelvic radiotherapy (WPRT) followed by a hypofractionated boost to the prostate with an intensity-modulated radiotherapy (IMRT) technique.
Identifiers		DOI: 10.1016/j.clon.2014.02.014 PMID: 24667210
Full text		Article (Published version) (365 Kb) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale
Research group		Groupe Miralbell Raymond (radio-oncologie) (685)
Citation (ISO format)		ZILLI, Thomas et al. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome. In: Clinical Oncology, 2014, vol. 26, n° 6, p. 316-22. doi: 10.1016/j.clon.2014.02.014 https://archive-ouverte.unige.ch/unige:44334